Lumenis Ltd. Announces Pricing of Its Initial Public Offering
February 27, 2014 10:30 ET
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Feb 27, 2014) - Lumenis Ltd. today announced the pricing of its initial public offering of 6,250,000 ordinary B shares at a price of $12.00 per share. In addition,...
Lumenis Ltd. Announces Launch of Initial Public Offering
February 13, 2014 19:14 ET
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Feb 13, 2014) - Lumenis Ltd. today announced that it has commenced an initial public offering of 6,250,000 ordinary B shares pursuant to a registration statement...
Lumenis Files Registration Statement for Proposed Public Offering and NASDAQ Listing
December 09, 2013 09:10 ET
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Dec 9, 2013) - Lumenis Ltd., a leading global provider of minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications, today announced...
Lumenis Receives US FDA and Japanese MHLW Clearance for Array(TM) LaserLink(TM) Pattern Scanning Device for Multi-Spot Retinal Laser Treatment
November 15, 2013 01:00 ET
|
Lumenis
SAN JOSE, CA--(Marketwired - Nov 15, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, surgical and aesthetic applications, today announced that the company has...
Lumenis Introduces Powerful New Solution for Killer Abdominal Cramps
October 16, 2013 03:00 ET
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Oct 16, 2013) - Killer cramps can be a thing of the past for women with conditions such as endometriosis, adhesions and uterine fibroids. Lumenis Ltd., the...
Lumenis Introduces Next-Generation CO2 Laser, the AcuPulse(TM) DUO: Empowering Surgeons With Ultimate Flexibility of Both Fiber & Free Beam Modalities on a Single Platform
September 23, 2013 09:00 ET
|
Lumenis
VANCOUVER, BC--(Marketwired - Sep 23, 2013) - Lumenis Ltd., the world's largest medical laser company for surgical, ophthalmic, and aesthetic applications, announced today the introduction of the...
Lumenis Receives FDA Clearance for ResurFX(TM), New Fractional Non-Ablative Module for M22(TM) Aesthetic Platform
September 16, 2013 09:00 ET
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Sep 16, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, surgical and aesthetic applications, today announced that the Company has...
Lumenis Expands Its Product Line in China Through Strategic Partnership With Visionix
July 25, 2013 09:00 ET
|
Lumenis
SAN JOSE, CA and JERUSALEM--(Marketwired - Jul 25, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, aesthetic, and surgical applications, and Visionix, a worldwide...
New Study by Dr. Tony Realini Demonstrates Lumenis SLT as a Powerful Tool for Reducing Glaucoma-Related Blindness in the Developing World
June 11, 2013 09:00 ET
|
Lumenis
SAN JOSE, CA--(Marketwired - Jun 11, 2013) - Lumenis Ltd. announced today that the company is pledging its support to the work of Tony Realini, MD, MPH, Associate Professor of Ophthalmology, West...
Lumenis(R) Supports Prestigious Moorfields Eye Hospital in Seminal Glaucoma Study Using Lumenis' Selective Laser Trabeculoplasty (SLT) Technology
May 07, 2013 04:00 ET
|
Lumenis
SAN JOSE, CA--(Marketwired - May 7, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, aesthetic, and surgical applications, and the pioneer of Selective Laser...